NCT01929473已完成不适用
Seroepidemiological Study of Pertussis and Other Infectious Diseases
Gifu Prefecture Medical Association0 个研究点目标入组 3,830 人开始时间: 2013年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,830
- 主要终点
- IgG
研究概览
简要总结
Serum samples will be corrected twice from the same youth subjects with one year interval.
Seroincidence of pertussis will be estimated by the elevation of Ig-G-PT in paired sera from an identical individual.
The relationship between the incidence and the demographic data or medical history of the subjects will be discussed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Students of junior high school, high schools or college in Gifu prefecture
- •Students who can have the second blood drawing one year later
- •Students (and their parent when students are underage) whose written consent is obtainable.
排除标准
- 未提供
结局指标
主要结局
IgG
时间窗: 0 day, 365 day (2 points)
Seroincidence of pertussis estimated by the elevation of Ig-G-PT in paired sera(0day, 365day).
次要结局
- Antibodies of Varicella, Mumps and Rubella(0 day)
- Incidence of Pertussis(0 day)
- Infection Risk Factors Including Family Numbers, Living Space, With or Without a Cough Patient in the Surroundings, Medical History and Hospitalization(365 day)
研究者
相似试验
已完成
不适用
Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis VaccinesPertussisNCT01129362Sanofi Pasteur, a Sanofi Company1,195
Unknown
不适用
Changes in Seroprevalence and Wellness Over Time in Healthcare Workers (CONSERVE-HCW)COVID-19 InfectionNCT04595175Brian Tiffany, MD2,000
已完成
不适用
Sero-epidemiological Survey of England in 2019/2020 - COVID-19Serogroup C Meningococcal MeningitisCOVID-19DiphtheriaNCT04061382University of Oxford2,963
Unknown
不适用
Population-based Age-stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection in the Federation of Bosnia and HerzegovinaSeroprevalenceAntibodyCOVID-19NCT05124535Institute for Public Health of the Federation of Bosnia and Herzegovina1,152
已完成
2 期
Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 YearsEncephalitis, Tick-borneNCT00161746Pfizer